Financial Reports Latest Updates Industry Maps Economic Calendar

MACROGENICS INC (MGNX) Annual Reports

Q: Where can I read MACROGENICS INC (MGNX) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

MACROGENICS INC is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1125345 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$32.8M	$22.2M	+47.6%
Operating income	$-13.9M	$-36.8M	+62.3%
Net income	$19.5M	$-36.3M	+153.8%
EPS (diluted)	$0.31	$-0.57	+154.4%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 32.8 mn Net income 19.5 mn

Show table：Income statement

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	57.2	20.5	17.4	16.1	9.80	10.6	12.3	20.2	14.9	14.7	9.22	18.4	5.48	71.3	6.72	14.7	8.18	2.85	80.7	3.26	5.11	2.06	1.67	1.66	152	4.70	18.8	20.8	15.8	9.66	10.6	18.7	25.2	13.7	20.3	18.3	52.7	16.9	30.8	15.7	14.2	11.1	26.0	41.7	73.1	24.5	13.1	10.4	10.7	9.10	10.8	111	19.4	13.2	22.2	72.8	41.2	20.8	32.8
Operating income	5.25	—	—	2.60	-2.26	-3.33	-0.25	7.16	-3.21	-3.11	-12.3	-3.93	-19.0	45.1	-21.3	-15.4	-28.6	-30.6	40.1	-34.3	-35.2	-38.2	-41.2	-47.7	105	-50.2	-44.3	-35.0	-41.7	-47.6	-53.0	-37.9	-38.6	-45.4	-47.3	-36.1	-2.17	-51.3	-40.3	-53.0	-58.2	-66.6	-41.8	-24.9	12.0	-38.4	-45.0	-35.5	-49.4	-53.8	-58.2	54.2	-52.8	-42.6	-36.8	18.6	-12.1	-33.4	-13.8
Net income	6.72	4.32	3.55	2.60	-2.10	-3.37	-0.29	6.60	-3.20	-3.11	-12.3	-3.93	-19.0	45.1	-21.4	-15.4	-28.4	-30.4	40.5	-33.9	-34.8	-37.6	-40.6	-47.0	106	-49.5	-43.2	-34.0	-44.6	-45.0	-31.8	-44.6	-30.4	-44.7	-46.9	-36.0	-2.09	-51.3	-39.9	-52.9	-58.0	-66.4	-41.3	-24.8	12.8	-38.0	57.5	17.6	-46.1	-52.2	-55.7	56.3	-15.4	-41.0	-36.3	16.8	-14.2	-36.8	19.5

Balance sheet

Quarterly · In mn (USD)

Total assets 345 mn Total liabilities 303 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	49.9	—	—	37.0	119	202	199	187	165	268	242	371	342	309	348	316	284	251	250	209	322	271	322	286	269	335	288	276	240	195	260	310	313	375	367	335	280	218	168	148	222	289	255	291	251	203	157	222	217	182	205	232	220	183	322
Total assets	—	—	—	—	53.8	—	—	42.0	126	210	206	194	174	278	254	384	359	326	369	340	311	275	275	242	374	326	387	355	332	415	384	351	313	265	328	374	379	435	426	392	335	271	218	195	280	344	306	340	298	248	201	264	262	225	245	271	257	218	345
Current liabilities	—	—	—	—	29.7	—	—	25.3	28.8	29.4	29.9	26.0	27.1	24.1	23.9	22.4	23.3	17.8	19.5	22.1	27.3	26.6	29.9	32.4	49.8	50.0	48.0	48.0	59.9	51.8	49.5	57.6	45.2	39.6	45.9	50.1	50.7	53.0	69.9	68.9	74.6	67.1	50.9	50.0	48.6	45.6	45.2	51.3	56.1	55.8	57.9	59.3	55.5	55.4	39.0	44.5	43.1	95.9	109
Total liabilities	—	—	—	—	62.0	—	—	46.0	46.9	57.0	63.7	54.5	52.6	47.1	42.5	44.8	45.9	39.4	38.9	39.8	42.5	40.1	43.5	52.4	74.7	78.8	74.9	72.7	89.3	94.0	89.2	96.3	81.9	74.8	79.8	82.8	82.9	84.9	107	101	95.6	93.2	75.6	72.4	138	234	134	146	146	142	143	144	146	145	199	204	201	197	303
Equity	-17.5	—	—	—	-8.24	—	—	-4.05	78.9	153	142	139	121	231	212	339	313	286	330	300	269	235	231	189	299	247	312	283	243	321	294	255	231	191	248	292	296	351	319	291	240	178	142	123	142	109	172	194	153	106	57.8	120	116	79.1	46.6	67.0	55.6	21.2	42.9

Cash flow

Quarterly · In mn (USD)

Operating -40.8 mn Investing 28.0 mn Financing 60.2 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	6.76	—	—	-24.3	17.7	-3.85	-9.95	0.81	-1.18	5.89	-4.15	-14.3	-20.2	43.6	-25.5	-7.63	-24.1	-31.9	-33.2	49.8	-28.3	-35.3	-30.8	-31.4	112	-31.3	-57.7	-37.0	-27.2	-30.0	-48.8	-17.4	-38.0	-44.1	-36.5	-25.7	-5.53	-29.0	-45.7	-14.8	-54.3	-57.7	-49.2	-9.42	29.3	-12.8	-2.09	-35.3	-28.0	-45.6	-44.5	60.2	-38.4	-46.9	-47.0	-30.2	43.0	-35.8	-40.8
Investing	-0.5	—	—	-0.53	-0.41	-0.43	-0.45	-1.16	-0.92	-0.45	-0.79	-0.67	-1.66	-1.00	-2.81	-2.61	-146	-12.5	-56.6	-3.16	2.03	-8.36	73.1	4.46	8.64	19.4	-7.81	-0.01	45.1	-70.5	-10.1	-6.37	7.63	10.6	41.0	-43.3	-16.1	-34.3	13.8	-2.62	-13.6	-18.5	23.0	72.0	-5.79	28.1	-113	-33.5	38.8	24.8	47.4	35.6	41.5	9.90	-37.6	-20.4	-66.0	45.3	28.0
Financing	12.1	—	—	0.04	0	0.06	0.65	0.14	85.0	76.8	0.24	0.18	0.22	63.0	0.17	141	0.25	0.22	0.13	1.01	0.49	0.11	33.7	1.15	0.36	0.63	104	0.13	0.48	119	0.63	0.04	0.3	0.16	99.0	74.1	1.10	101	2.35	19.0	0.8	0.04	0.26	0	1.36	100	0.06	49.9	0.27	0.25	0.63	-0.07	0.16	-0.28	69.7	0	0.06	-0.21	60.2
Cash at period end	55.2	—	—	30.4	47.7	43.5	33.8	33.6	116	199	194	179	158	263	235	366	196	152	62.3	110	84.1	40.5	117	90.9	212	200	239	202	220	239	180	157	126	93.1	197	202	181	219	189	191	123	47.3	21.5	84.0	109	224	109	89.9	101	80.4	83.9	180	183	146	131	80.1	57.2	66.5	114

Profitability

Quarterly · %

Operating margin -42.2% Net margin 59.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	9.2%	—	—	16.2%	-23.0%	-31.4%	-2.1%	35.4%	-21.5%	-21.1%	-133.0%	-21.4%	-347.3%	63.3%	-317.0%	-105.2%	-349.5%	-1076.3%	49.7%	-1052.7%	-690.1%	-1859.3%	-2471.7%	-2869.8%	68.9%	-1069.4%	-235.3%	-168.3%	-263.9%	-492.8%	-500.0%	-202.5%	-153.4%	-332.1%	-233.6%	-198.0%	-4.1%	-303.9%	-131.0%	-338.3%	-411.6%	-600.3%	-160.8%	-59.8%	16.4%	-156.9%	-342.3%	-341.5%	-460.4%	-590.4%	-538.9%	49.0%	-273.0%	-323.1%	-165.3%	25.6%	-29.3%	-161.0%	-42.2%
Net margin	11.7%	21.1%	20.3%	16.2%	-21.5%	-31.8%	-2.4%	32.6%	-21.5%	-21.1%	-133.0%	-21.4%	-347.3%	63.3%	-318.3%	-105.2%	-347.9%	-1066.9%	50.2%	-1039.8%	-681.2%	-1832.4%	-2440.2%	-2828.8%	69.4%	-1055.1%	-229.6%	-163.6%	-282.7%	-465.9%	-299.9%	-238.2%	-120.7%	-326.9%	-231.4%	-197.5%	-4.0%	-303.7%	-129.8%	-337.7%	-410.1%	-598.5%	-158.8%	-59.5%	17.5%	-155.2%	437.5%	168.8%	-429.8%	-573.3%	-515.5%	50.9%	-79.7%	-311.1%	-163.0%	23.1%	-34.3%	-177.0%	59.4%

Returns & leverage

Quarterly · %

ROE -32.6% ROA -4.9% Debt ratio 87.6%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	—	-0.7%	0.0%	-8.4%	-33.3%	-38.3%	5.2%	0.5%	-4.5%	-9.3%	-37.0%	-12.5%	-16.3%	-20.1%	-25.3%	-52.4%	-65.4%	-6.9%	-13.1%	-12.6%	-8.9%	-63.3%	-58.8%	-51.3%	-61.8%	-64.1%	-59.3%	-61.5%	-57.8%	-49.3%	-50.4%	-45.6%	-50.1%	-75.5%	-82.2%	-94.8%	-92.0%	-62.8%	-63.5%	4.7%	31.4%	-6.2%	-21.6%	-118.9%	-62.2%	-49.9%	-60.3%	-69.7%	-81.1%	-87.0%	-140.3%	-32.6%
ROA	—	—	—	—	15.6%	—	—	2.0%	-0.3%	0.0%	-5.8%	-19.1%	-25.6%	4.1%	0.3%	-3.7%	-7.6%	-31.7%	-10.8%	-14.4%	-17.5%	-21.9%	-45.6%	-55.1%	-5.7%	-10.5%	-10.3%	-7.1%	-48.6%	-45.1%	-40.4%	-47.0%	-47.1%	-44.6%	-46.9%	-43.5%	-37.5%	-38.9%	-34.3%	-38.1%	-56.6%	-61.5%	-67.9%	-64.9%	-38.9%	-29.7%	2.8%	18.6%	-3.1%	-7.8%	-53.8%	-32.3%	-23.9%	-23.6%	-16.3%	-28.4%	-28.8%	-31.8%	-4.9%
Debt ratio	—	—	—	—	115.3%	—	—	109.6%	37.3%	27.1%	31.0%	28.2%	30.3%	16.9%	16.7%	11.7%	12.8%	12.1%	10.5%	11.7%	13.7%	14.6%	15.8%	21.7%	20.0%	24.2%	19.4%	20.5%	26.9%	22.7%	23.3%	27.4%	26.2%	28.2%	24.4%	22.1%	21.9%	19.5%	25.1%	25.7%	28.5%	34.4%	34.6%	37.1%	49.4%	68.2%	43.9%	42.9%	48.9%	57.3%	71.3%	54.6%	55.6%	64.8%	81.0%	75.3%	78.4%	90.3%	87.6%

EPS

Quarterly · US$

EPS US$0.31

Show table：EPS

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	0.00	0.00	0.00	0.00	-1.92	-2.93	-0.24	0.01	-0.14	-0.12	-0.44	-0.14	-0.69	1.42	-0.71	-0.46	-0.83	-0.88	1.12	-0.97	-1.00	-1.08	-1.14	-1.28	2.80	—	—	—	—	—	—	—	—	—	-0.94	-0.66	0.02	-0.90	-0.66	-0.86	-0.95	-1.08	-0.67	-0.40	0.21	-0.61	0.92	0.28	-0.75	-0.84	-0.89	0.90	-0.25	-0.65	-0.57	0.27	-0.22	-0.58	0.31

Revenue & profit

Year-to-date · In mn (USD)

Revenue 53.6 mn Net income -17.3 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 345 mn Total liabilities 303 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -76.6 mn Investing 73.3 mn Financing 60.0 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -88.2% Net margin -32.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -32.6% ROA -4.9% Debt ratio 87.6%

EPS

Year-to-date · US$

EPS US$-0.27

Revenue & profit

Annual · In mn (USD)

Revenue 150 mn Net income -74.6 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	63.8	58.0	47.8	101	91.9	158	60.1	64.2	105	77.5	152	58.8	150	150
Operating income	—	0.37	-38.3	-20.2	-60.0	-22.1	-171	-177	-131	-203	-121	-168	-111	-72.8
Net income	8.36	-0.26	-38.3	-20.1	-58.5	-19.6	-171	-152	-130	-202	-120	-9.06	-67.0	-74.6

Balance sheet

Annual · In mn (USD)

Total assets 257 mn Total liabilities 201 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	49.9	119	165	342	284	322	269	240	313	280	222	251	217	220
Total assets	53.8	126	174	359	311	374	332	313	379	335	280	298	262	257
Current liabilities	29.7	28.8	27.1	23.3	27.3	49.8	59.9	45.2	50.7	74.6	48.6	56.1	55.5	43.1
Total liabilities	62.0	46.9	52.6	45.9	42.5	74.7	89.3	81.9	82.9	95.6	138	146	146	201
Equity	-8.24	78.9	121	313	269	299	243	231	296	240	142	153	116	55.6

Cash flow

Annual · In mn (USD)

Operating -81.0 mn Investing -114 mn Financing 69.5 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	—	-14.2	-32.8	-13.7	-43.7	14.4	-153	-134	-112	-144	-87.0	-78.2	-68.4	-81.0
Investing	—	-2.96	-3.57	-152	-70.3	77.9	56.6	-79.4	-7.78	-36.6	70.7	-80.1	149	-114
Financing	—	85.9	77.4	204	1.85	35.4	105	120	174	123	1.66	150	0.96	69.5
Cash at period end	47.7	116	158	196	84.1	212	220	126	181	123	109	101	183	57.2

Profitability

Annual · %

Operating margin -48.7% Net margin -49.9%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	—	0.6%	-80.2%	-20.0%	-65.3%	-14.0%	-284.8%	-276.0%	-125.0%	-261.9%	-79.9%	-286.4%	-73.7%	-48.7%
Net margin	13.1%	-0.5%	-80.2%	-20.0%	-63.7%	-12.4%	-285.2%	-236.5%	-123.7%	-261.0%	-78.8%	-15.4%	-44.7%	-49.9%

Returns & leverage

Annual · %

ROE -87.0% ROA -28.8% Debt ratio 78.4%

Show table：Returns & leverage

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	-0.7%	-38.3%	-9.3%	-20.1%	-6.9%	-63.3%	-64.1%	-49.3%	-75.5%	-62.8%	-6.2%	-49.9%	-87.0%
ROA	15.6%	-0.3%	-25.6%	-7.6%	-17.5%	-5.7%	-48.6%	-47.1%	-37.5%	-56.6%	-38.9%	-3.1%	-23.9%	-28.8%
Debt ratio	115.3%	37.3%	30.3%	12.8%	13.7%	20.0%	26.9%	26.2%	21.9%	28.5%	49.4%	48.9%	55.6%	78.4%

EPS

Annual · US$

EPS US$-1.17

Show table：EPS

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	-1.92	-3.30	-1.39	-0.58	-1.73	-0.70	—	—	—	-3.37	-1.94	-0.16	-1.08	-1.17

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read MACROGENICS INC (MGNX) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.